IPOPLUS

₹38.38

▲ +5.13 +15.43%

16 Jun 2026

NSE Listed · Pharmaceuticals

Vineet Laboratories Ltd. (VINEETLAB)

Volume: 1,640Avg Vol 1W: 4,056Avg Vol 1M: 8,58052W Range:₹26.97₹49.99
NSE BSE vineetlabs.co.in
₹38.38▲ 15.43%
Key Ratios
Updated just now
Market Cap—
Current Price₹38.38
Previous Close₹33.25
High / Low (52w)₹49.99 / ₹26.97
Volume1,640
Avg Vol (1W)4,056
Avg Vol (1M)8,580
Stock P/E—
Book Value₹15.42
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹56 Cr
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹0.92
P/B2.49
Debt / Equity—
50 DMA₹36.68
200 DMA₹33.24
Day change+15.43%
Price Chart
₹34.89▼ 16.93% · 1Y
₹48₹297.0L
2025-10-01
2026-06-16

20-day avg volume: 6K shares

Cons
  • Revenue fell 49% YoY.
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricDec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021
Revenue₹16 Cr₹17 Cr₹7 Cr₹14 Cr₹18 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹2 Cr₹3 Cr₹0 Cr₹-12 Cr₹-5 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹1 Cr₹0 Cr₹-1 Cr₹-11 Cr₹-6 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS0.920.36-0.79—-6.19-1.98-2.312.09-2.242.62-1.363.851.51-5.11.13.521.480.781.382.18
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS-21.91.111.367.162.180
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹95 Cr₹117 Cr₹116 Cr₹133 Cr₹0 Cr₹0 Cr
Total Liabilities₹80 Cr₹82 Cr₹82 Cr₹100 Cr₹0 Cr₹0 Cr
Equity₹15 Cr₹35 Cr₹34 Cr₹33 Cr₹0 Cr₹0 Cr
Total Debt₹40 Cr₹44 Cr₹31 Cr₹31 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹11 Cr₹-7 Cr₹-10 Cr₹8 Cr₹0 Cr
Investing₹-3 Cr₹-2 Cr₹-7 Cr₹-4 Cr₹0 Cr
Financing₹-8 Cr₹8 Cr₹0 Cr₹12 Cr₹0 Cr
Free Cash Flow₹10 Cr₹-9 Cr₹-17 Cr₹8 Cr₹0 Cr
Shareholding
Promoter 5.98% Institutions 0.36% Public 93.66%
About Vineet Laboratories Ltd.

Pharmaceuticals · Pharmaceuticals - Indian - Bulk Drugs & Formln

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search